Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Dottikon ES Holding

Dottikon ES Holding
1913 FOUNDED
PUBLIC STATUS
501-600 EMPLOYEES
DESN STOCK SYMBOL
3 INVESTMENTS
$597.58 SHARE PRICE (As of Monday Closing)
Description

Dottikon ES Holding AG manufactures high quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients for the chemical and pharmaceutical industry.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Multi-line Chemicals
Stock Exchange
SWX
Primary Office
  • Hembrunnstrasse 17
  • 5605 Dottikon
  • Switzerland

+41 056 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Dottikon ES Holding’s full profile, request a free trial.

Dottikon ES Holding Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$423.92 - $605.55 $601.50 $23.85 146.71

Dottikon ES Holding Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 578,518 511,022 838,949 746,730
Revenue 169,868 149,143 163,021 153,554
EBITDA 58,256 40,273 48,493 49,114
Net Income 29,840 16,415 26,616 22,423
Total Assets 485,291 465,082 459,727 380,311
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Dottikon ES Holding Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Dottikon ES Holding‘s full profile, request access.

Request full access to PitchBook

Dottikon ES Holding Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000 Failed Transaction (M&A) Paris, France 000000&0
To view this company’s complete list of competitors, request access »

Dottikon ES Holding Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 0000 19-Dec-2014 000000000 Electronic Equipment and Instruments 000000 0000000
0000000 (000000000 02-Aug-2012 000000000000000000 Drug Discovery
Systag System Technik 08-Dec-2005 Corporate Electronic Equipment and Instruments 000000 0000000
To view this company’s complete investment and acquisition history, request access »

Dottikon ES Holding Executive Team (2)

Name Title Board
Seat
Contact
Info
Markus Blocher Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »